| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |